saxagliptin

saxagliptin (ONGLYZA) is an FDA-listed pharmaceutical active ingredient. Associated with AstraZeneca. Route of administration: oral. Current US regulatory status: approved.

ONGLYZA is a marketed brand name for saxagliptin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

saxagliptin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.